Key result
Over 90% of hypertensive patients would take mid-life antihypertensives to prevent or delay dementia.
Why the study?
Patient preferences and concerns regarding the use of antihypertensive medications for dementia prevention were not well characterized.
Are patients willing to take antihypertensive medications for the purpose of dementia prevention?
Cross-Sectional (n=1,661)
Are patients willing to take antihypertensive medications for the purpose of dementia prevention?
Patients currently on antihypertensives are highly willing to take specific blood pressure medications for dementia prevention, though they have concerns about side effects, evidence, and cost.
Answers are grounded in this paper and cite their sources.
Supports trials of antihypertensives for dementia prevention; leaves open efficacy and safety data before practice change.
We administered a mixed-method survey to 1,661 patients in a large health system to assess preferences toward antihypertensive use for dementia prevention. If a specific antihypertensive medication was shown to prevent or delay dementia, the vast majority (>90%) of respondents currently taking an antihypertensive reported that they would be willing to take that specific antihypertensive starting as early as mid-life. Concerns reported were potential side effects, lack of evidence of effectiveness, blood pressure being normal or low, and medication cost. Analysis of free-text responses revealed themes of concerns regarding evidence of effectiveness and health priorities.
No takes yet. Share an insight, caveat, or question.
Marcum et al. (2019) conducted a cross-sectional in Patient preferences toward antihypertensive use for dementia prevention (n=1,661). Antihypertensive medication for dementia prevention was evaluated on Willingness to take a specific antihypertensive starting as early as mid-life. Over 90% of patients currently taking an antihypertensive would be willing to take a specific antihypertensive starting in mid-life if it were shown to prevent or delay dementia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: